Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 1388Neoplasms 1167Colorectal Neoplasms 626Lung Neoplasms 562Prostatic Neoplasms 538Carcinoma, Non-Small-Cell Lung 444Carcinoma, Hepatocellular 296Stomach Neoplasms 272Pancreatic Neoplasms 270Colonic Neoplasms 264Ovarian Neoplasms 231Head and Neck Neoplasms 228Rectal Neoplasms 221Melanoma 216Multiple Myeloma 204Uterine Cervical Neoplasms 198Lymphoma 195Leukemia 193Precursor Cell Lymphoblastic Leukemia-Lymphoma 191Neoplasm Metastasis 178Carcinoma, Renal Cell 177Brain Neoplasms 174Esophageal Neoplasms 173Leukemia, Myeloid, Acute 158Urinary Bladder Neoplasms 138Recurrence 123Polycystic Ovary Syndrome 122Liver Neoplasms 119Hematologic Neoplasms 117Endometrial Neoplasms 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Observational × Proteus Syndrome × Clear all
NCT01369953 2018-07-26

Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants

National Institutes of Health Clinical Center (CC)

Completed
30 enrolled
Head & Neck

Hyperparathyroidism 2, Coronary Artery Disease, Proteus Syndrome, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡